Claudia Guida

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion.

GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion.

Journal: Diabetologia
Published: August 16, 2023

Loss of electrical β-cell to δ-cell coupling underlies impaired hypoglycaemia-induced glucagon secretion in type-1 diabetes.

Loss of electrical β-cell to δ-cell coupling underlies impaired hypoglycaemia-induced glucagon secretion in type-1 diabetes.

Journal: Nature metabolism
Published: July 18, 2023

Theoretical study of the interactions between peptide tyrosine tyrosine [PYY (1-36)], a newly identified modulator in type 2 diabetes pathophysiology, with receptors NPY1R and NPY4R.

Theoretical study of the interactions between peptide tyrosine tyrosine [PYY (1-36)], a newly identified modulator in type 2 diabetes pathophysiology, with receptors NPY1R and NPY4R.

Journal: Hormones (Athens, Greece)
Published: September 25, 2020

Gs/Gq signaling switch in β cells defines incretin effectiveness in diabetes.

Gs/Gq signaling switch in β cells defines incretin effectiveness in diabetes.

Journal: The Journal of clinical investigation
Published: May 08, 2020

Somatostatin secretion by Na+-dependent Ca2+-induced Ca2+ release in pancreatic delta-cells.

Somatostatin secretion by Na+-dependent Ca2+-induced Ca2+ release in pancreatic delta-cells.

Journal: Nature metabolism
Published: January 30, 2020

PYY, a Therapeutic Option for Type 2 Diabetes?

PYY, a Therapeutic Option for Type 2 Diabetes?

Journal: Clinical medicine insights. Endocrinology and diabetes
Published: October 25, 2019

PYY plays a key role in the resolution of diabetes following bariatric surgery in humans.

PYY plays a key role in the resolution of diabetes following bariatric surgery in humans.

Journal: EBioMedicine
Published: September 14, 2018

Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.

Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.

Journal: Diabetes, obesity & metabolism
Published: June 06, 2017

The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes.

The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes.

Journal: Trends in endocrinology and metabolism: TEM
Published: February 27, 2017
Showing 1-9 of 9

Last Updated: 09/26/2026